Policy and Medicine Archive for January, 2021

Click a link below to view the mailing archive as if it had been sent to you.

2021-01-29 12:30		Insys Therapeutics Founder Settles with the State of New Jersey Over Role in Opioid Epidemic
2021-01-28 12:30		AMA to Advocate for Telemedicine Access, Even After COVID-19
2021-01-27 12:30		PhRMA Announces Principles on Clinical Trial Diversity
2021-01-26 12:30		Final Rule Released on the 340B Dispute Process
2021-01-25 12:30		CMS Updates Guidance on Sunshine Act Reporting Thresholds for 2021
2021-01-22 12:30		ACCME Releases 2019 Data Report
2021-01-21 12:30		California Genetic Testing Lab Resolves False Claims Act Allegations
2021-01-20 12:30		OPDP Sends Six Warning and Untitled Letters in 2020 – Final Letter Sent to Azurity Pharmaceuticals
2021-01-19 12:30		FDA Finalizes Guidance Regarding Complex Products Meetings
2021-01-18 12:30		FDA Releases Draft Question and Answers Guidance on Interchangeable Products
2021-01-15 12:30		COVID-19 Public Health Emergency Declaration Renewed
2021-01-14 12:30		CMS Issues Guidance Outlining Opportunities for Addressing Social Determinants
2021-01-13 12:30		HHS OIG Releases Report on Opioid Use in Appalachian States
2021-01-12 12:30		Twenty-Eight States Demand Laws Be Enforced on 340B Drug Pricing
2021-01-11 12:30		Biogen Settles False Claims Act Allegations with the DOJ
2021-01-08 12:30		MIPS Extreme and Uncontrollable Circumstances Exception Application Deadline Extended to February 1, 2021
2021-01-07 12:30		Senate Finance Committee Report Calls for Greater Drug Industry Transparency on Payments to Non Profits
2021-01-06 12:30		Estimated Improper Medicare Payments Down $15 Billion Since 2016
2021-01-05 12:30		Home Health Agency Agrees to Settle False Claims Act Allegations
2021-01-04 12:30		CMS Releases 2021 MPFS and QPP Updates

<< Archive Index • Subscribe >>